Office

Westray, Tower 1

6363 greenwood plaza blvd centennial, co, 80111, centennial, CO 80111

Price

Price on request

Description

Westray, just steps from light rail and adjacent to Fiddler’s Green, is coming to Centennial in early 2022. A new kind of work environment that turns Class AA office space into premium fuel for business. Thoughtful. Anticipatory. It is form following function. And yet it acknowledges that inspiration and joy are essential functions. Westray thinks about people. How they live and work. And what they need in order to live and work better. Westray takes one little corner of the world - namely, the workplace - and lifts it up. Literally. Schnitzer West is developing 868,000 square feet of dynamic, Class AA office, including 25,000 square feet of retail amenities. The plan for Westray includes three buildings, which will be built in three phases. The first building is scheduled for completion in early 2022. Every element will be designed to create a premier workplace experience. There are workplaces. And there are places that make work … work better.

Property description as provided by the listing source. PropZone adds independent market context, valuation estimates, and comparable listings.

Location

6363 greenwood plaza blvd centennial, co, 80111, centennial, CO 80111

Leaflet © OpenStreetMap contributors

Market Context

As of Q2 2017, the Denver office market showed average asking rents near $8.40/SF/yr. Source: multiple brokerages Q2 2017 market report.

Compare it against other office listings for sale in Centennial, CO to benchmark pricing and space — view the full market.

Unified Estimate

Medium Confidence

$133.66/SF-$180.84/SF

Mid: $157.25/SF

Rate estimator only; cost-of-business estimate unavailable.

Sale Price History

2023 – 2026 · county sold comps + market trendsFIPS 08005

High Confidence

Avg Rent ($/SF/yr) (market data)
Median $/SF (sold)

Market asking rent (quarterly avg)Median sale price / SFP25–P75 IQR band

Investment Analysis

Beta Feature: Investment Analysis is currently in beta testing. Metrics are calculated based on available financial data and market comparables. Results are for informational purposes and should not be considered financial advice. Verify all assumptions and consult with a financial advisor before making investment decisions.